Nikolai Podoltsev

29PUBLICATIONS
112CO-AUTHORS
Regenerative medicine (incl. stem cells)Haematological tumoursForensic epidemiologyMedical mycologyMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Jun 02, 2026
Selinexor Plus Ruxolitinib in Janus Kinase Inhibitor-Naïve Myelofibrosis: Phase III SENTRY Trial.

|Apr 25, 2026
Acute myeloid leukemia after myeloproliferative neoplasms: Real-world outcomes in the new treatment era in the United States.

|Sep 18, 2025
Luspatercept for patients with lower-risk myelodysplastic syndromes/neoplasms: a systematic review and meta-analysis.

Abdulrahman Alhajahjeh, Naira Link Woite, Benjamin Rolles

|Jul 28, 2025
Cost-effectiveness of upfront vs delayed allogeneic hematopoietic stem cell transplant for intermediate risk AML.

Abdulrahman Alhajahjeh, Kishan K Patel, Nikolai A Podoltsev

|May 06, 2025
Synergistic Activity of Combined FLT3-ITD and MDM2 Inhibition with Quizartinib and Milademetan in FLT3-ITD Mutant/TP53 Wild-type Acute Myeloid Leukemias.

Weiguo Zhang, Li Li, Muharrem Muftuoglu

|Dec 02, 2024
Global Disparities in the Characteristics and Outcomes of Leukemia Clinical Trials: A Cross-Sectional Study of the ClinicalTrials.gov Database.

Abdulrahman Alhajahjeh, Lara K Rotter, Jessica M Stempel

Pageof 5

Frequent Collaborators

10 joint publications

Rory M Shallis

8 joint publications

Scott F Huntington

5 joint publications

Jan Philipp Bewersdorf

4 joint publications

Jessica M Stempel